GHC is led by Executive Director Christine Sow and a dedicated staff, based out of Washington, DC.


Executive Director


CSOW_GHC_3Dr. Christine Sow

Dr. Christine Sow is the President and Executive Director of the Global Health Council, the leading membership organization supporting and connecting advocates, implementers and stakeholders around global health priorities worldwide. With more than 20 years of global health leadership experience, she has led numerous initiatives to strengthen health systems and increase access to life-saving drugs and services. Over the span of her career, Dr. Sow has worked for non-profit, academic, bilateral and multilateral agencies and spent more than 15 years in West Africa with organizations including UNICEF and USAID. She received a PhD in epidemiology from Tulane University and two Masters Degrees from the University of Michigan. Dr. Sow is currently a delegate to the World Bank’s Civil Society Consultative Group for Health, Nutrition and Population and a member of the Global Work Group of the Advisory Committee to the Director of the Center for Disease Control and Prevention.

Board of Directors

Under the leadership of Dr. Jonathan Quick, the Board members represent the nonprofit, private, and public health sectors, and have years of experience in advocacy, communications, finance, public health, and international development.

In 2014, GHC held a nomination process to elect new Board members for 2015.  Currently, GHC has 20 Board members (see below).

Dr. Akudo Anyanwu Ikemba

Akudo Anyanwu Ikemba.Friends of Africa.Dr. Ikemba is Founder and CEO of Friends Africa (Friends of the Global Fund Africa). For three years, she served as Technical Advisor for Global Fund Projects in Nigeria, under Columbia University’s Access Project. In this role, she provided technical assistance to countries to enable them access and manage the Global Fund to Fight AIDS TB Malaria (GFATM) and successfully secured $480 million in funding for Nigeria from the Global Fund. She has worked for the Centers for Disease Control – (CDC) in Atlanta, Georgia and as an Associate Scientist with Life Technologies in Palo Alto, California. She is currently a World Economic Forum Young Global Leader for years 2012-­2017.

Dr. Ikemba has also worked as a lecturer at Tufts University School of Medicine and has done extensive molecular biology research at Tufts University and Katholique University, Belgium on DNA analysis of Cryptosporium parvum and the motilin protein respectively. She holds a Doctorate degree in medicine from Tufts University, a Master of International Public Health from Harvard University, and a Bachelor of Science degree in Molecular Biology from Lehigh University. She has also done postgraduate studies at the University of London and the London Hospital for Tropical Diseases.

Her interests are in infectious diseases, economic development and in public­private partnerships for health in developing countries. Dr. Ikemba is deeply affected by Africa’s astoundingly poor health indicators and the low quality of health systems and infrastructure. Her life goal is to play a pivotal leadership role in improving Africa’s health status and development as a whole.


Term expires December 31, 2015.

Dr. Ayo Ajayi

Ayo Ajayi, MD, MPH, began work at the Bill & Melinda Gates Foundation in November 2014. Previously he led strategy development and implementation for PATH country programs in Asia, Africa, Eastern Europe, and Latin America and the Caribbean.

Before joining PATH in 2008, Dr. Ajayi worked for 16 years with the Population Council, serving as regional director for sub-Saharan Africa. Previously, he was Africa regional vice president for Pathfinder International, served as a government health officer in Nigeria, and taught at Boston University School of Public Health.

Dr. Ajayi has served on numerous occasions as technical advisor and program evaluator for the US Agency for International Development, the World Health Organization, and several other United Nations agencies and private foundations. He is a founding board member of the Burkitt’s lymphoma Kenya Fund and serves on the boards of Ibis Reproductive Health and the Positive Action for Children Fund.

Dr. Ajayi earned his MD from the University of Ibadan Medical School in Nigeria. He received an MPH and a distinguished alumnus award from Boston University School of Public Health with a concentration in health systems; and he completed a postgraduate certificate program in family planning impact evaluation at the London School of Hygiene & Tropical Medicine.

Term expires December 31, 2018.

Ms. Elizabeth Creel

Liz Creel John Snow IncMs. Elizabeth (Liz) Creel is the director of the Advancing Partners & Communities Project (APC), implemented by John Snow Inc.’s (JSI) APC advances and supports community programs that improve the overall health of communities and achieve other health-related impacts, especially in relationship to family planning. Her specialties include program management, policy development, strategic communications and advocacy.

Ms. Creel has over two decades of experience in international public health with the U.S. government and with various development organizations. Prior to joining APC, Ms. Creel led a multidisciplinary communications team, in support of the U.S. Agency for International Development’s Global Health Bureau and managed and coordinated public policy, advocacy and communications efforts for several non-profits. In addition, Ms. Creel served as a senior technical officer on family planning and population issues for the Population Reference Bureau and worked as a project manager for the U.S. Environmental Protection Agency on global efforts to restore the ozone depletion and mitigate climate change.

Ms. Creel has a master’s degree in public health from the George Washington University School of Public Health and a master’s degree in international relations/economics from the Johns Hopkins University School of International Studies.

Term expires December 31, 2015.

Mr. Jason Taylor Wright

Jason Taylor Wright AidsAllianceMr. Wright is the U.S. Director of the International HIV/AIDS Alliance after having assuming the position in October 2011. The AIDS Alliance is a network of national, independent, locally governed and managed Linking Organizations working in 40 countries. He is based in Washington. Mr. Wright most recently was Multilateral Team Leader in the Office of HIV/AIDS at the U.S. Agency for International Development (USAID) in Washington. He served as USAID Liaison to the Global Fund to Fight AIDS, Tuberculosis, and Malaria and the Joint United Nations Program on HIV/AIDS (UNAIDS) and was the longest ­serving member of the U.S. Government delegations to the Global Fund Board and UNAIDS Program Coordinating Board (PCB). His multilateral team managed the U.S. Government Global Fund technical assistance portfolio. He previously was Donor Coordination Advisor in the Office of Strategic Planning, Budgeting, and Operations at USAID and HIV/AIDS Policy Advisor in the Office of Global Health Affairs at the U.S. Department of Health and Human Services in Washington.

He earned a Master of Science in Foreign Service (MSFS) and a Master of Arts (MA) in History from Georgetown University in Washington and a Bachelor of Arts (BA) summa cum laude in Political Economy and German from Tulane University in New Orleans.

Term expires December 31, 2015.

Dr. Jonathan Quick, Board Chairman

dr-quickDr. Quick serves as interim chair of the Global Health Council’s Board of Directors. He is a family physician and health management specialist and is the President and CEO of Management Sciences for Health (MSH). An international non­profit organization with teams in Africa, Asia, and Latin America, MSH builds local capacity to achieve greater health impact through stronger health systems. Dr. Quick was Director of Essential Drugs and Medicines Policy at the World Health Organization from 1996 to 2004. Prior to that, he served with MSH as founding director of the Drug Management program/center for pharmaceutical management, then as a long-term advisor for the Afghanistan Health Sector Support Project and the Kenya Health Care Financing Project.

Dr. Quick has worked in international health since 1978, and has carried out assignments in over 50 countries in Africa, Asia, Latin America, and the Middle East. He is the senior editor of Managing Drug Supply, co­author of the Financial Times Guide to Executive Health, and has written over 70 other books, articles, and chapters. He is on the faculty of the Harvard Medical School Department of Global Health and Social Medicine and the Boston University School of Public Health, and is a Fellow of the Royal Society of Medicine. He has a first degree from Harvard University and a Doctor of Medicine, with distinction in research, and Master of Public Health from the University of Rochester.

Term expires December 31, 2015.

Ms. Karen Goraleski

The Sherwood Group August 3, 2011. Photo by Andrew Collings.Ms. Goraleski is Executive Director of the American Society of Tropical Medicine and Hygiene, a worldwide organization of scientists, clinicians and program professionals, whose mission is to promote global health through the prevention and control of infectious and other diseases that disproportionately impact the world’s poorest individuals. Ms. Goraleski oversees all aspects of the Society’s efforts, which include: the American Journal of Tropical Medicine and Hygiene; the CTropMed® Certificate of Knowledge in Clinical Tropical Medicine and Travelers’ Health; the Annual Meeting, which attracts a global audience and is widely considered the premier meeting in tropical medicine; and a portfolio of activities that includes awards and research opportunities, policy development, advocacy and membership.

An experienced presenter, knowledgeable in the translation of complex issues for decision makers, media and public, Ms. Goraleski has led national and local workshops for the science community that focus on innovative advocacy using strategies designed to help a non­science audience better understand the value and importance of a strong U.S. investment in research.

Earlier positions included executive roles at the American Medical Association and the American Hospital Association, both in Chicago. As Chief of Staff to the AMA’s Senior Vice President for Professional Standards, Ms. Goraleski integrated activities of 125 staff and a $12.5 million budget. As Associate Director of the American Society for Health Care Marketing and Public Relations at the AHA, she planned, managed and evaluated professional educational programs and directed its national professional award program.

Ms. Goraleski received a Master of Social Work from the Jane Addams College of Social Work at the University of Illinois at Chicago and a Bachelor of Arts from St. Xavier University in Chicago.

Term expires December 31, 2015.

Dr. Keith Martin

Martin_KeithDr. Martin is the Senior Advisor at the Consortium of Universities for Global Health (CUGH) and a distinguished leader in global health. He spent 17 years as a Canadian Member of Parliament, acting in many senior roles in the areas of foreign affairs, international development, defense, and environment. He has taken a leadership role in these areas in North America and internationally. Dr. Martin is widely connected to the global health community across a broad range of disciplines. As CUGH’s Senior Advisor and point person in our Washington, D.C. office, Dr. Martin is ideally suited to help catalyze strong, synergistic collaborations between CUGH and GHC.

Term expires December 31, 2015.

Mr. Kent Hill


Kent Hill joined World Vision in February 2011 after more than three decades serving in U.S. government, academic, and nonprofit leadership roles. As head of international programs for World Vision U.S., Hill collaborates with the international partnership of World Vision to help facilitate the overseas allocation of resources from government grants, corporate donated goods, and individual donors. Hill is based in the Washington, D.C., office.

Hill served from 2001 to 2005 as U.S. Agency for International Development (USAID) Assistant Administrator of Europe and Eurasia, and was responsible for U.S. foreign assistance to 26 countries in Eastern Europe and the former Soviet Union. Between 2005 and 2009, he was Assistant Administrator of the Bureau for Global Health, heading up all USAID health programs and representing USAID in several interagency, global, and multilateral health initiatives. Hill has extensive experience with multiple U.S. government departments and agencies, international assistance agencies from other countries, and hundreds of U.S. and international NGOs, including faith-based organizations. He received a master’s degree in Russian Studies and a Ph.D. in history from the University of Washington; spent six years as an associate professor of history at Seattle Pacific University; was president of the Institute on Religion and Democracy in Washington, D.C.; and later served as president of Eastern Nazarene College in Quincy, Massachusetts. Most recently, Hill spent two years as the vice president for character development for the John Templeton Foundation.

Term expires December 31, 2018.

Mr. Kyle Peterson

Kyle_Peterson2LKyle Peterson is a thought leader in shared value, corporate philanthropy, and global health and development issues. He has worked with the world’s leading companies and funders, including the Shell Oil Company, Aetna, Eli Lilly & Company, Pfizer, Verizon, Merck, Abbott Labs, Novartis, the Bill and Melinda Gates Foundation, PATH, and the David and Lucile Packard Foundation.
Kyle has led many of FSG’s global health development engagements and has been a key contributor to the firm’s shared value, catalytic philanthropy, and collective impact frameworks. He speaks frequently at social sector and industry conferences and roundtable events. Prior to joining FSG, Kyle served as a strategy consultant at the Monitor Group where he wrote a major regional economic study with Professor Michael Porter and led a competitiveness consulting project for President Paul Kagame and his cabinet on Rwanda’s economic strategy. Kyle was also a country director in Zimbabwe and Rwanda for Population Services International, where he managed a $20 million program and launched a number of health product “firsts” on the African continent, including mass marketed insecticide treated mosquito nets, female condoms, and a novel network of HIV/AIDS voluntary counseling and testing centers.

Mr. Leonard S. Rubenstein

Len Rubenstein JHUMr. Rubenstein is Senior Scholar at the Center for Human Rights and Public Health at the Johns Hopkins Bloomberg School of Public Health and has a joint appointment at the Berman Institute of Bioethics at Johns Hopkins University. At Hopkins, he founded the Safeguarding Health in Conflict Coalition, which brings together global health, human rights, humanitarian, and health professional communities to advance protection of health in situations of conflict. Mr. Rubenstein has served as Jennings Randolph Senior Fellow at the United States Institute of Peace (2008­2009), Executive Director and then President of Physicians for Human Rights (1996­2009) and Executive Director of the Judge David Bazelon Center for Mental Health Law (1991­1996). Mr. Rubenstein has written extensively both for scientific journals and in major media and is a member of the Council on Foreign Relations, the Committee on Scientific Freedom and Responsibility of the American Association for the Advancement of Science and the Board of Directors of the International Federation of Health and Human Rights Organizations. He has served on the board of directors of InterAction and global health organizations, as well as on the Governing Council of the American Public Health Association, where he now is a member of APHA’s Human Rights Committee and Action Board. He is the recipient the Congressional Minority Caucuses’ Healthcare Hero Award and the APHA Award for Peace.

Term expires December 31, 2015.

Ms. Loyce Pace

LP Bass headshotLoyce Pace is Director of Health Policy for the LIVESTRONG Foundation. She leads the Foundation’s agenda to promote legislation, regulations and standards in favor of people worldwide affected by or at risk for cancer. In her current position, Loyce communicates the link between research, practice and policy to decision-makers across diverse sectors in the United States and abroad. She has been invited to speak as an expert on the health policy response to cancer challenges at myriad domestic and international events, including those sponsored by World Health Organization, U.S. Centers for Disease Control and Prevention, The Corporate Council on Africa, and a number of other organizations and universities. She also has delivered testimony on global health policy to members of the U.S. House of Representatives.

Before joining the Foundation, Loyce was Director of Regional Programs for the American Cancer Society’s Department of Global Health, responsible for developing their first capacity-building and advocacy programs in Southeast Asia and sub-Saharan Africa. She launched the US-based NCD Roundtable under the auspices of the Global Health Council. She also served as an International Development Fellow for Catholic Relief Services, working throughout Senegal and The Gambia. Loyce holds a Bachelor’s degree with Honors in Human Biology from Stanford University and a Master’s degree in Public Health from Johns Hopkins Bloomberg School of Public Health, where she was inducted into the Delta Omega Society. In addition to serving on the board of Global Health Council, she is a member of Phillips Academy (Andover) Alumni Council. She has lived in Africa, Asia, and Europe, and currently resides near Washington, DC.

Mr. Michael P. Tarnok

M Tarnok_HeadshotMichael P. Tarnok, 59 has served on the Board of Directors of Keryx Biopharmaceuticals, Inc. since September 2007 and as Chairman of the Board Since June 2009. Mr. Tarnok served as interim chief executive officer from April 2009 to May 2009. He is a seasoned finance and operational executive with extensive pharmaceutical industry experience in a wide range of functional areas. Mr. Tarnok spent the majority of his career at Pfizer Inc., which he joined in 1989 as Finance Director-US Manufacturing and from 2000-2007 served as Senior Vice President, Finance in Pfizer’s US Pharmaceutical Division. In this position, Mr. Tarnok handled all financial responsibilities for the division including contracting, trade management, forecasting of significant product launches and Sarbanes-Oxley compliance. He also served as General Manager of the company’s Greenstone generics division. Prior to joining Pfizer, Mr. Tarnok worked primarily in financial disciplines for ITT Rayonier, Inc., Celanese Corporation and Olivetti Corporation of America. Mr. Tarnok earned an M.B.A in Marketing from New York University and a B.S. in Accounting from St. John’s University.

Ms. Nasserie Carew

Nasserie Carew is Senior Advisor to the Assistant Secretary of Public Affairs and to the State Department’s Ebola Coordination Unit (ECU).  Ms. Carew leads the bureau’s Ebola communications and other outreach efforts.

Ms. Carew served from 2010-2014 as the Managing Director of Public Affairs at the Millennium Challenge Corporation, a U.S. Government foreign assistance agency, where she implemented a broad range of communications functions, working with leadership in the White House and across government agencies.  From 2005-2010, she oversaw strategic messaging on sustainable development issues and humanitarian emergencies as the Senior Director of Public Relations at InterAction, the largest coalition of U.S. based international humanitarian and development organizations.

A veteran of issues management, Ms. Carew has led strategic communications for international and national media, major stakeholders, and policy makers over the past 20 years.  She established digital communication strategies, major alliances, reputation management programs and integrated global branding processes. Ms. Carew also managed communications and advertising for the multimillion dollar national re-brand and positioning for YWCA USA.

Ms. Carew earned a B.Sc. from the University of Iowa and a Master’s degree from Howard University.

Term expires December 31, 2018.

Ms. Pat Daly

Pat DalyMs. Daly is the Deputy Director of the Department of Health and Nutrition for Save the Children. Her work in international public health for more than 30 years exemplifies a strong commitment to improving the lives of women and children. Ms. Daly has many years of experience with working with NGOs, including more than a decade with Save the Children.

Over the past ten years, she has served as Deputy Director of the USAID Global Partnership, Maternal and Child Integrated Partnership (MCHIP), and ACCESS, the USAID global award for maternal and newborn health. Ms. Daly was also the Deputy Director of Save the Children’s Saving Newborn Lives Initiative, funded by the Bill & Melinda Gates Foundation, in which she helped lead and shape efforts to improve neonatal health worldwide. From 1994­2000, Ms. Daly worked with the World Bank in Washington and Indonesia as a technical advisor for safe motherhood and community health and nutrition. She worked with John Snow, Inc., in Nepal and in Senegal as a technical advisor on Primary Health Care with USAID/Senegal. Ms. Daly has lived in Indonesia, Nepal and Senegal and has over 30 years of experience in international health, including 14 years overseas in Asia and Africa, with specialized expertise in maternal, newborn and child health.

Ms. Daly has dedicated her professional career to advancing reproductive, maternal, newborn and child health. She is a strong advocate for the continuum of care from reproductive, maternal to newborn to child health and from household to hospital. Ms. Daly also advocates for issues of concern to NGOs, and is committed to being an advocate for communities and local NGOs, whose voices often go unheard.

Term expires December 31, 2015.

Ms. Paurvi Bhatt


Paurvi Bhatt is the Senior Director for Global Access at Medtronic Philanthropy where she leads a multimillion dollar global strategic grants portfolio that focuses on empowering people impacted by NDCs, enabling frontline health workers, and advancing the policy dialogue to increase access to care for the undeserved.

She is a seasoned global health leader with deep multi-sectoral experience in business, nonprofit, and government sectors. She spearheaded global programs in several private companies including at Levi Strauss and Co. and Abbott. Ms. Bhatt has also managed global health technical portfolios at USAID and CARE USA. She has also served as an international evaluator at the U.S. General Accountability Office. Her technical expertise is in HIV/AIDS, women’s health and health systems and economics. She serves on several human resources, international health and HIV/AIDS working groups, technical advisory committees, and is on several Boards including the Global Business Group on Health, AIDSUnited, and GlobeMed.

She holds a Masters of Public Health in health systems and economics from Yale University, and Bachelor Degree in neuroscience from Northwestern University.

Dr. Peter J. Donaldson

PeterDonaldson.PopulationCouncilDr. Donaldson is the President of the Population Council, as appointed by its board of trustees in January 2005. His first postdoctoral employment was as a Council staff associate in Thailand (1973–75) and a representative in South Korea (1975–77). He then spent eight years at Family Health International in North Carolina, where he served ultimately as Director of Development and Government Relations. From 1985 to 1989, Dr. Donaldson was the Director of the Committee on Population of the National Research Council. In 1989, he returned to the Council to become a senior associate and Regional Director for South and East Asia, once again located in Thailand. He was the Chief Executive Officer of the Washington, DC-based Population Reference Bureau from 1994 to 2003.

Dr. Donaldson rejoined the Population Council in 2003 as Vice President and Director of the International Programs Division, the Council’s largest division, and also served as acting president prior to becoming president. In addition to his management and leadership responsibilities, Dr. Donaldson served on the board of directors of the Population Association of America, on the council of the Population Section of the American Sociological Association, and as a member of the advisory committee of the Institute for Population and Social Research, Mahidol University, Bangkok.

Dr. Donaldson earned a Ph.D. in sociology from Brown University, as well as Master’s and Bachelor’s degrees from Fordham University. In 2010, he received an honorary doctorate from Mahidol University in Thailand. Dr. Donaldson has written or edited six books and numerous articles for both scientific and popular publications on population, development, and Asian affairs.

Term expires December 31, 2015.

Ms. Rachel Wilson

RachelWilson.PATH.Ms. Wilson is Senior Director of Policy and Advocacy at PATH, and responsible for the development, management, and evaluation of the organization’s advocacy and public policy initiatives. In this role, Ms. Wilson oversees the advocacy and public policy department at PATH, which consists of 24 staff who work with partners in the U.S., Europe, Asia, and Africa to inform the global health policies and priorities of bilateral donors, global multilaterals, and national governments in low resource settings. Ms. Wilson oversees an advocacy portfolio that ranges from topics of maternal, newborn, child health and malaria to global health research and development and regulatory policy. She has held numerous advisory roles, with entities including the Global Health Technologies Coalition, Women Deliver, the UN Every Woman Every Child Innovation Working Group, the Maternal Health Supplies Working Group, the U.S. Coalition for Child Survival, the Global Network for Neglected Tropical Diseases, and the Stop TB Partnership. PATH is an international nonprofit organization that transforms global health through innovation.

Term expires December 31, 2015.

Mr. Robert Marten

Robert Marten

Robert Marten joined The Rockefeller Foundation in 2010. Mr. Marten manages relationships with current and prospective grantees throughout the grantmaking process, coordinates Foundation work with partners, and conducts research in support of the strategic development and execution of Foundation initiatives. He works on the Transforming Health Systems (THS) initiative.

Prior to joining The Rockefeller Foundation, Mr. Marten worked as a consultant with the World Bank, the World Health Organization and German Technical Cooperation in Zambia and South Africa. He also worked as a researcher at the Global Public Policy Institute in Germany and served as a United Nations Volunteer on HIV/AIDS in Vietnam.

Mr. Marten received a bachelor’s degree from McGill University, a master’s degree in public policy from the Hertie School of Governance, a certificate in global health effectiveness from the Harvard School of Public Health, a master’s degree in public health from Johns Hopkins University and is pursuing a doctoral degree from the London School of Hygiene and Tropical Medicine.

Term expires December 31, 2018.

Mr. Tracy Sims

Tracy Sims sized 2

Tracy Sims is Senior Advisor for Global Corporate Affairs at Eli Lilly and Company and is Leader for Corporate Affairs for Lilly’s Access Expansion organization. Lilly is an innovation focused, research and development based, biopharmaceutical corporation with global operations.

In his 25-year professional career Tracy has held roles in government, non-profit, and the private sector. A 20-year Lilly veteran, he has extensive experience in designing and implementing healthcare outcome improvement efforts world-wide. Tracy led the strategy design of Lilly’s U.S. patient assistance programs with novel efforts specific to Medicare Part D. He led strategy development and implementation of Phase III for the Lilly MDR-TB Partnership which is a $30M, 5-year effort to improve health outcomes for underserved populations affected by MDR-TB in China, India, Russia, and South Africa. Additionally, he led strategy development and implementation of Phase I for the Lilly NCD Partnership which is a $30M, 5-year effort to improve health outcomes for underserved populations affected by diabetes in Brazil, India, Mexico, and South Africa. Most recently, Tracy has led corporate affairs efforts associated with sustainably improving access to Lilly’s diabetes care products in China and India.

Tracy holds a bachelor of arts degree in communications and history from Whitworth University from which he graduated with honors.

Term expires December 31, 2018.